Brief: Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(C)(4)
20/12/2024 21:54
Dec 20 (Reuters) -
* ULTRAGENYX REPORTS INDUCEMENT GRANT UNDER NASDAQ LISTING
RULE
5635(C)(4)
Source text: ID:nGNX12mC8t
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ultragenyx Pharmaceutical
See all newsBrief: Ultragenyx Pharmaceutical Enters Settlement Agreement With Navinta On Dojolvi Patent Litigation - SEC Filing
Ultragenyx gains on $210 million US FDA voucher sale
Brief: Ultragenyx Pharmaceutical - Under Deal With U.S. Department Of Health Co To Pay 20% Of Prv Sale Proceeds To Nih
Brief: Ultragenyx Enters Into Agreement To Sell Rare Pediatric Disease Priority Review Voucher For $210 Million
U.S. STOCKS ON THE MOVE-CoreWeave, StubHub, Ultragenyx